FDA Inspection 1160903 — Sinai Hospital Of Baltimore Blood Bank
The FDA completed an inspection of Sinai Hospital Of Baltimore Blood Bank on Dec 29, 2021 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 29, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Baltimore, MD (United States)